Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Restauration of EBV Control in SLE Phase 1-2 Trial Evaluating Adoptive Transfer of Autologous EBV- Specific Cytotoxic T Lymphocytes in SLE Treatment

NCT02677688 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT02677688
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02677688 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Restauration of EBV Control in SLE Phase 1-2 Trial Evaluating Adoptive Transfer of Autologous EBV- Specific Cytotoxic T Lymphocytes in SLE Treatment
Lead sponsor
Nantes University Hospital
Phase
Phase 1/2
Overall status
Terminated
Start date
January 31, 2016
Completion date
July 1, 2021
Enrollment
9 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

serologically active adult systemic lupus erythematosus